Mizuho raises Cabot stock price target to $90 on battery growth

Cabot raised by Mizuho to a $90 price target from $80, while Truist initiated coverage at Buy with a $98 target, reflecting constructive analyst sentiment. The company also beat Q2 FY2026 expectations with EPS of $1.61 versus $1.46 consensus and revenue of $904 million, helped by growth in performance chemicals and battery materials. Management highlighted battery materials growth of about 45% and a 2026 EBITDA target of roughly $40 million, supporting the longer-term outlook.

Analysis

Cabot is increasingly a two-speed story: the market is still anchoring on cyclical carbon black/reinforcement exposure, while the incremental value is being created in higher-multiple specialty and battery-adjacent niches. That mix matters because even modest EBITDA from battery materials can re-rate the stock if investors start assigning it a strategic-growth multiple rather than a commodities multiple; the current setup suggests the market may be underestimating how much of the valuation support now comes from segment mix, not just absolute earnings.

The second-order winner here is the battery supply chain outside the U.S., especially stationary storage and China EV infrastructure, where materials quality and dispersion performance are more important than pure cost. If Cabot continues to gain share in conductive additives/nanomaterials, the pressure lands on smaller specialty material players that lack the same installed customer relationships or technical credibility, while traditional carbon-black peers remain stuck with lower multiple, oil-linked end markets. The key implication: this is less a near-term earnings pop and more a 12-24 month narrative shift if management keeps compounding in adjacent high-growth chemistries.

The main risk is that the market is extrapolating too quickly from a small base. Battery materials may be growing fast, but at only a low-single-digit share of total EBITDA today, any disappointment in ramp timing, qualification cycles, or customer concentration could cause the growth premium to compress back into the core cyclical valuation. If tire and industrial demand weakens simultaneously, the company loses the stabilizing effect that currently makes the story look cleaner than the underlying end-markets really are.

Consensus may be missing that the real catalyst is not just earnings beats, but a reclassification event: if investors conclude the battery and semiconductor materials businesses are durable, Cabot can sustain a higher multiple even without heroic near-term EPS revisions. Conversely, if these businesses remain viewed as optionality rather than core earnings, the stock could stall near current levels despite continued operational execution.

Key Decisions for Investors

• Long CBT on pullbacks over the next 2-4 weeks; target a re-rate toward the low-$100s if the market starts valuing battery materials as a growth annuity rather than a call option. Risk is a rapid multiple fade back below current trading levels if the next update lacks segment-level acceleration.
• Pair trade: long CBT / short a more purely cyclical carbon-black or tire-input peer over 1-3 months to isolate mix-improvement upside. This works best if oil remains rangebound and end-demand stays stable, because CBT has a cleaner path to multiple expansion.
• Buy CBT Jan-2026 upside calls or call spreads to express the thesis that the valuation re-rating will take quarters, not days. Use strikes just above the current price to keep theta manageable; risk is low if battery EBITDA growth disappoints.
• Take profits on any sharp post-print extension; near-term upside may be limited because the stock is already close to fair-value assumptions. Best entry is on weakness, not chase, unless management provides explicit 2026 margin/EBITDA bridge on the next call.